Top Altcoins ETF Approvals: Bloomberg’s Predictions
Key Points: Top Altcoins ETF Approvals see rising odds, with Litecoin ETF at 90% approval probability, followed by Dogecoin, Solana, and XRP ETFs. SEC’s stance on altcoin ETFs shifts post-Trump, signaling potential regulatory clarity and increased institutional confidence. Top Altcoins ETF Approvals gain traction as SEC considers filings for XRP, Solana, Dogecoin, and Litecoin, reflecting shifting regulatory policies in the U.S. Top Altcoins ETF Approvals: SEC’s Changing Stance on Crypto A wave of altcoin ETF applications, including those for XRP, Solana, Dogecoin, and Litecoin, has been submitted to the U.S. SEC under the 19b-4 process. Notably, for the first time, the SEC has officially acknowledged new ETF filings for Solana and Litecoin, indicating a more receptive stance toward crypto ETFs. According to Bloomberg analysts James Seyffart and Eric Balchunas, these Top Altcoins ETF Approvals have the highest approval odds in history. They estimate the likelihood as follows: Litecoin ETF: 90% Dogecoin ETF: 75% Solana ETF: 70% XRP ETF: 65% Estimated SEC Approval Rate for Altcoins ETFs Predicted by Two Bloomberg AnalystsPrior to the 2024 U.S. presidential election, approval odds for these ETFs were below 5%. However, with Trump’s administration embracing pro-crypto policies, regulatory sentiment has shifted dramatically. Balchunas commented: “Before Trump’s election, altcoin ETF approvals (except Litecoin) were below 5%. Now, their chances have surged and may continue rising as filings progress.” This shift marks a departure from former SEC Chair Gary Gensler’s stringent approach, which frequently delayed or rejected altcoin ETF applications, particularly Solana’s. The new administration’s stance has sparked optimism among institutional investors. Read more: Binance Proof of Reserves Plummets by $8 Billion Institutional Confidence in Top Altcoins ETF Approvals Among the pending altcoin ETFs, Litecoin ETF (LTC) leads with a 90% approval probability due to its strong regulatory compliance track record. Canary Capital and Grayscale have filed applications, awaiting the SEC’s final decision. Conversely, XRP ETF faces the most legal challenges due to the ongoing Ripple vs. SEC lawsuit. Despite a favorable federal court ruling for Ripple in July 2023, SEC’s continued appeals could delay XRP ETF approval. Seyffart stated: “That until that WHOLE mess of litigation between Ripple/XRP and the SEC is settled and/or finished or has some sort of expected outcome etc etc — you likely won’t see an ETF. The SEC needs to untangle that mess.” Nevertheless, Cboe BZX Exchange has submitted 19b-4 filings for four XRP ETFs from top asset managers, including WisdomTree, Bitwise, 21Shares, and Canary Capital. This move signals strong institutional confidence in Top Altcoins ETF Approvals despite regulatory uncertainty. Under the leadership of SEC Commissioner Mark Uyeda, the agency is reassessing crypto regulations. Analysts predict that XRP and Dogecoin ETFs may be formally acknowledged as early as this week. James Seyffart predicts that the XRP and Dogecoin (DOGE) TF ETF could be officially recognized as early as this week.Moreover, Grayscale has filed the first-ever Cardano ETF application, submitted by NYSE Arca on February 11. Following this announcement, ADA’s price surged 16%, reaching a $28.24 billion market cap. ADA price movement in the last 24 hours, screenshot on CoinMarketCap at 01:00 PM on February 11, 2025However, Cardano, Solana, and XRP remain on the SEC’s list of securities from past lawsuits against Binance and Coinbase. Final ETF approval depends on regulatory classification clarity, which may emerge by late 2025 when SEC’s crypto task force, led by Commissioner Hester Peirce, finalizes its guidelines. If the SEC proceeds with these approvals, it would be a landmark moment for institutional crypto adoption, setting a precedent for future Top Altcoins ETF Approvals and strengthening crypto’s integration into traditional finance. DISCLAIMER: The information on this website is provided as general market commentary and does not constitute investment advice. We encourage you to do your own research before investing.